NCT04708249View on ClinicalTrials.gov

D-chiroinositol Administration in Hypogonadal Males

NACompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

January 18, 2021

Primary Completion Date

February 24, 2021

Study Completion Date

March 1, 2021

Conditions

Male HypogonadismSexual Dysfunction

Interventions

DIETARY_SUPPLEMENT

D-chiroinositol

Supplementation with 600 mg of D-chiroinositol, two-times daily on an empty stomach, for 30 days.

Trial Locations (1)

00198

Clinica Alma Res, Rome

Sponsors

Lead Sponsor

Lo.Li.Pharma s.r.l

All Listed Sponsors

lead

Lo.Li.Pharma s.r.l

INDUSTRY